Menu

MERS Update

An outbreak of Middle East respiratory syndrome in South Korea has now sickened more than 150, killing 19.

Jun 16, 2015
Kerry Grens

PIXABAY, SSALAEThe latest death toll from an outbreak of Middle East respiratory syndrome (MERS) in South Korea is up to 19, CNN reported Monday (June 15), with 154 people having contracted the illness. Another 5,500 people have been quarantined in their homes or in designated facilities.

Health officials are hopeful that quarantine measures will end the outbreak in South Korea by July, according to Voice of America. “At this point, everything is under control and if an additional cluster does not occur, the final date will be June 27th,” said Kwon Jun-Wook, MERS taskforce leader in the country’s Ministry of Health and Welfare.

The World Health Organization (WHO) last week (June 12) reported that scientists have sequenced the genome of the virus in the South Korean outbreak. “Preliminary analysis of these findings does not suggest that a more transmissible virus is emerging in Korea,” WHO stated on its website. “An explanation for the rapid expansion of Korea’s outbreak almost certainly lies elsewhere.”

All of the cases so far have been linked to healthcare facilities. “One factor that may be unique to South Korea, however, is the practice of ‘doctor shopping,’” ScienceInsider reported June 13. “The initial patient, who fell ill after returning from a business trip through several Middle East countries, visited four clinics and hospitals before being diagnosed with MERS on 20 May. Such behavior increases the chances of viral spread.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.